Kiminobu Tanizawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kiminobu Tanizawa has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Akihiko Yoshizawa
Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan
2 shared publications- Issei Oi
Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
2 shared publications - Kohei Fujita
National Hospital Organization Kyoto Medical Center
2 shared publications - Osamu Kanai
Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
2 shared publications - Shogo Toyama
Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, Kyoto-City, Kyoto, Japan
2 shared publications Takanori Ito
Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
2 shared publications
Latest Publications
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA5246
Longitudinal Quantitative Chest Computed Tomography Analysis of Idiopathic Pulmonary Fibrosis
Background: AIQCT is an artificial intelligence -based quantitative computed tomography (CT) image analysis software and was previously applied for cross-sectional evaluation of patients with idiopathic pulmonary fibrosis (IPF) Aims and Objectives: To investigate the clinical relevance of longitudinal quantitative changes in CT images of IPF. Methods: A retrospective observational study at a single interstitial lung disease (ILD) center. In 78 patients with IPF, CT images at baseline and 12 months later were quantitatively evaluated by AIQCT. The associations of 12-month changes in AIQCT indices (presented as the percentage of the whole lungs) with baseline clinical and AIQCT parameters, 12-month changes in pulmonary function tests and overall survival were analyzed. Results: Median absolute 12-month changes in normal area, fibrosis (reticulation and honeycombing) and ILD (fibrosis and ground-glass opacity) measured by the AIQCT were -3.0% [interquartile ranges, -0.8, 5.9], 0.9% [0.2, 2.1], and 0.8% [-0.2, 3.0]. Absolute 12-month changes in fibrosis and ILD were associated with fibrosis and ILD at baseline. An absolute 12-month change in fibrosis was associated with the percentage of predicted forced vital capacity (%DLCO) at baseline. Absolute 12-month changes in fibrosis and ILD correlated with 12-month changes in the percentage of predicted forced vital capacity (%FVC) (|r|=0.50-0.62) and %DLCO (|r|=0.24-0.34). An absolute 12-month increase in fibrosis predicted the mortality, independent of 12-month decline in %FVC and antifibrotic therapy (adjusted hazard ratio = 1.22) and fibrosis at baseline (adjusted hazard ratio = 1.17). Conclusions: The AIQCT may be useful to define the disease behavior of IPF in addition to physiological measurements.
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA5246
Longitudinal Quantitative Chest Computed Tomography Analysis of Idiopathic Pulmonary Fibrosis
Background: AIQCT is an artificial intelligence -based quantitative computed tomography (CT) image analysis software and was previously applied for cross-sectional evaluation of patients with idiopathic pulmonary fibrosis (IPF) Aims and Objectives: To investigate the clinical relevance of longitudinal quantitative changes in CT images of IPF. Methods: A retrospective observational study at a single interstitial lung disease (ILD) center. In 78 patients with IPF, CT images at baseline and 12 months later were quantitatively evaluated by AIQCT. The associations of 12-month changes in AIQCT indices (presented as the percentage of the whole lungs) with baseline clinical and AIQCT parameters, 12-month changes in pulmonary function tests and overall survival were analyzed. Results: Median absolute 12-month changes in normal area, fibrosis (reticulation and honeycombing) and ILD (fibrosis and ground-glass opacity) measured by the AIQCT were -3.0% [interquartile ranges, -0.8, 5.9], 0.9% [0.2, 2.1], and 0.8% [-0.2, 3.0]. Absolute 12-month changes in fibrosis and ILD were associated with fibrosis and ILD at baseline. An absolute 12-month change in fibrosis was associated with the percentage of predicted forced vital capacity (%DLCO) at baseline. Absolute 12-month changes in fibrosis and ILD correlated with 12-month changes in the percentage of predicted forced vital capacity (%FVC) (|r|=0.50-0.62) and %DLCO (|r|=0.24-0.34). An absolute 12-month increase in fibrosis predicted the mortality, independent of 12-month decline in %FVC and antifibrotic therapy (adjusted hazard ratio = 1.22) and fibrosis at baseline (adjusted hazard ratio = 1.17). Conclusions: The AIQCT may be useful to define the disease behavior of IPF in addition to physiological measurements.
- Open Access
- 28 March 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Bronchoscopic removal of lower airway foreign body: a two-center retrospective cohort study
Background: Tracheobronchial foreign body (FB) aspiration is a life-threatening condition, particularly in older adults. Despite its clinical significance, research on the etiology of adult FB aspiration, as well as real-world outcomes and complications associated with FB removal in lower airways, remains limited. Patients and methods: This was a two-center retrospective cohort study in Japan. We included adult patients aged 18 years or older who underwent bronchoscopic FB removal between April 2010 and March 2025. Results: A total of 28 patients were included in this analysis (mean age, 75.4 years [median age: 75 years]; range, 55–102 years). Nineteen patients (67.9%) were male. The most frequently reported symptoms were coughing (46.4%), sputum production (39.3%), and dyspnea (17.9%). A total of 30 FBs were identified, with dental prostheses (60.0%) being the most common type, followed by natural teeth (10.0%). FBs were slightly more common on the right side (53.3%) than on the left side (43.3%), with the right lower lobe being the most frequent site of lodgement (30.0%), followed by the left lower lobe (20.7%). The most frequently bronchoscopic findings were mucosal edema (36.7%) and bleeding (26.7%). FB removal was performed using flexible bronchoscopy in 26 patients (92.9), with the exception of two cases (7.1%) in which rigid bronchoscopy was employed. Bronchoscopy was performed in the endoscopy room for 21 patients (75.0%). Among the 28 patients, standard forceps were used in 24 (85.7%), followed by basket forceps, which was employed in 10 patients (35.7%). FB removal was successful in 26 (92.9%) patients. Regarding adverse events, hypoxia was the only complication observed, occurring in 18 patients (64.3%); no other adverse events were reported. Conclusions: Most FB in the lower airways can be successfully and safely removed via flexible bronchoscopy.
- 28 March 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Open AccessBronchoscopic removal of lower airway foreign body: a two-center retrospective cohort study
Background: Tracheobronchial foreign body (FB) aspiration is a life-threatening condition, particularly in older adults. Despite its clinical significance, research on the etiology of adult FB aspiration, as well as real-world outcomes and complications associated with FB removal in lower airways, remains limited. Patients and methods: This was a two-center retrospective cohort study in Japan. We included adult patients aged 18 years or older who underwent bronchoscopic FB removal between April 2010 and March 2025. Results: A total of 28 patients were included in this analysis (mean age, 75.4 years [median age: 75 years]; range, 55–102 years). Nineteen patients (67.9%) were male. The most frequently reported symptoms were coughing (46.4%), sputum production (39.3%), and dyspnea (17.9%). A total of 30 FBs were identified, with dental prostheses (60.0%) being the most common type, followed by natural teeth (10.0%). FBs were slightly more common on the right side (53.3%) than on the left side (43.3%), with the right lower lobe being the most frequent site of lodgement (30.0%), followed by the left lower lobe (20.7%). The most frequently bronchoscopic findings were mucosal edema (36.7%) and bleeding (26.7%). FB removal was performed using flexible bronchoscopy in 26 patients (92.9), with the exception of two cases (7.1%) in which rigid bronchoscopy was employed. Bronchoscopy was performed in the endoscopy room for 21 patients (75.0%). Among the 28 patients, standard forceps were used in 24 (85.7%), followed by basket forceps, which was employed in 10 patients (35.7%). FB removal was successful in 26 (92.9%) patients. Regarding adverse events, hypoxia was the only complication observed, occurring in 18 patients (64.3%); no other adverse events were reported. Conclusions: Most FB in the lower airways can be successfully and safely removed via flexible bronchoscopy.
- Open Access
- 16 December 2025
- Published by Springer Nature in BMC Research Notes
- Vol. 19 (1)
Single-centre retrospective experience of complications and outcomes of computed tomography-guided lung biopsy and interventions for the management of intrathoracic infections
Objective: To investigate the complications and outcomes of computed tomography (CT)-guided lung biopsy and interventions in the management of intrathoracic infections. Results: Twenty-nine patients were examined. Eleven (37.9%) patients were diagnosed with pulmonary nodules, and 18 (62.1%) underwent drainage of lung abscesses. The median age of the patients was 77 years, and 44.8% had a poor performance status. The major underlying diseases were hypertension and malignancies. The puncture site was mostly the right lower lobe (44.8%), whereas there were no cases of puncture in the left upper lobe. The nodule diagnostic success rate was 54.5% and the success rate of lung abscess drainage was 88.9%. The common organisms identified were Aspergillus , S. pneumoniae and S. aureus in the nodules and S. intermedius in the lung abscess drainage. Pigtail catheters were most commonly used for drainage (50%). Pneumothorax and hypoxaemia were the most common adverse events (13.8%), followed by fever (10.3%). Clinical trial registration : This retrospective study was registered in the UMIN Clinical Trials Registry (registration No. UMIN000055755). This clinical trial was registered on 6 October 2024 and is publicly available.
- 16 December 2025
- Published by Springer Nature in BMC Research Notes
- Vol. 19 (1)
Open AccessSingle-centre retrospective experience of complications and outcomes of computed tomography-guided lung biopsy and interventions for the management of intrathoracic infections
Objective: To investigate the complications and outcomes of computed tomography (CT)-guided lung biopsy and interventions in the management of intrathoracic infections. Results: Twenty-nine patients were examined. Eleven (37.9%) patients were diagnosed with pulmonary nodules, and 18 (62.1%) underwent drainage of lung abscesses. The median age of the patients was 77 years, and 44.8% had a poor performance status. The major underlying diseases were hypertension and malignancies. The puncture site was mostly the right lower lobe (44.8%), whereas there were no cases of puncture in the left upper lobe. The nodule diagnostic success rate was 54.5% and the success rate of lung abscess drainage was 88.9%. The common organisms identified were Aspergillus , S. pneumoniae and S. aureus in the nodules and S. intermedius in the lung abscess drainage. Pigtail catheters were most commonly used for drainage (50%). Pneumothorax and hypoxaemia were the most common adverse events (13.8%), followed by fever (10.3%). Clinical trial registration : This retrospective study was registered in the UMIN Clinical Trials Registry (registration No. UMIN000055755). This clinical trial was registered on 6 October 2024 and is publicly available.
- Open Access
- 1 December 2025
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 58
A case of clopidogrel-induced organizing pneumonia evaluated by lung biopsy and confirmed by accidental re-administration
- 1 December 2025
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 58
Open AccessA case of clopidogrel-induced organizing pneumonia evaluated by lung biopsy and confirmed by accidental re-administration